drugset

drugset / Trial / NCT00095043

Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)

NCT00095043 ↗

Phase 3 Completed 320 enrolled H. Lundbeck A/S

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to study the safety of MK0928 on insomnia in the elderly.

Timeline

Start: 2004-10
Primary completion: 2006-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	gaboxadol	Small molecule	—	—

Indications